Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma

被引：0

作者：

Guarneri, Valeria ^{[1
]}

Loggi, Elisabetta ^{[2
]}

Serra, Carla ^{[3
]}

Vukotic, Ranka ^{[4
]}

Cevenini, Monica ^{[4
]}

Cursaro, Carmela ^{[4
]}

Scuteri, Alessandra ^{[4
]}

Vitale, Giovanni ^{[3
]}

Margotti, Marzia ^{[4
]}

Galli, Silvia ^{[5
]}

Galli, Claudio ^{[6
]}

Andreone, Pietro ^{[7
]}

机构：

[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[2] ASUR4, Operat Unit Clin Pathol, Fermo, Italy

[3] Univ Bologna, Dept Organ Failure & Transplantat, Bologna, Italy

[4] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[5] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[6] Abbott Diagnost, Med & Sci Affairs, Rome, Italy

[7] Univ Modena & Reggio Emilia, Dept Med Sci, Modena, Italy

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI470

引用

页码：S631 / S632

页数：2

共 50 条

[1] Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma
Guarneri, V.
Loggi, E.
Serra, C.
Vukotic, R.
Cevenini, M.
Cursaro, C.
Scuteri, A.
Vitale, G.
Margotti, M.
Galli, S.
Andreone, P.
[J]. CLINICA CHIMICA ACTA, 2019, 493 : S147 - S147
[2] Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients
Huang, Shujing
Jiang, Feifei
Wang, Ying
Yu, Yanhua
Ren, Siqian
Wang, Xiaowei
Yin, Peng
Lou, Jinli
[J]. TUMOR BIOLOGY, 2017, 39 (06)
[3] The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
Basile, U.
Miele, L.
Napodano, C.
Ciasca, G.
Gulli, F.
Pocino, K.
De Matthaeis, N.
Liguori, A.
De Magistris, A.
Marrone, G.
Biolato, M.
Marino, M.
Di Giacinto, F.
Gasbarrini, A.
Grieco, A.
Rapaccini, G. L.
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (24) : 12675 - 12685
[4] Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
Zakhary, Nadia I.
Khodeer, Sherif M.
Shafik, Hanan E.
Malak, Camelia A. Abdel
[J]. JOURNAL OF ADVANCED RESEARCH, 2013, 4 (06) : 539 - 546
[5] THE SIGNIFICANCE OF PIVKA-II TO HEPATOCELLULAR CARCINOMA PROGNOSIS
Shamsdin, S. A.
Zahmatkeshan, M.
Badiee, P.
Hashemzadeh, Z.
[J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S311 - S311
[6] The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
Xu, Fei
Zhang, Lulu
He, Wenting
Song, Di
Ji, Xiaomeng
Shao, Jianyong
[J]. DISEASE MARKERS, 2021, 2021
[7] Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
An, Shu
Zhan, Xiaoxia
Liu, Min
Li, Laisheng
Wu, Jian
[J]. DIAGNOSTICS, 2023, 13 (08)
[8] Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma
Kaneko, Shun
Kurosaki, Masayuki
Tsuchiya, Kaoru
Yasui, Yutaka
Hayakawa, Yuka
Inada, Kento
Tanaka, Yuki
Ishido, Shun
Kirino, Sakura
Yamashita, Koji
Nobusawa, Tsubasa
Matsumoto, Hiroaki
Kakegawa, Tatsuya
Higuchi, Mayu
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Tamaki, Nobuharu
Takahashi, Yuka
Nakanishi, Hiroyuki
Izumi, Namiki
[J]. PLOS ONE, 2022, 17 (03):
[9] Diagnostic value of PIVKA-II in detecting hepatocellular carcinoma in Chinese patients with hepatitis B virus infection
Tang, Xiao-Qiong
Li, Hong
Yan, Li-Bo
Zhou, Ling-Yun
Chen, En-Qiang
Liu, Miao
Zhang, Dong-Mei
Tang, Hong
[J]. FUTURE VIROLOGY, 2017, 12 (05) : 259 - 267
[10] Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Pote, Nicolas
Cauchy, Franois
Albuquerque, Miguel
Voitot, Helene
Belghiti, Jacques
Castera, Laurent
Puy, Herve
Bedossa, Pierre
Paradis, Valerie
[J]. JOURNAL OF HEPATOLOGY, 2015, 62 (04) : 848 - 854

← 1 2 3 4 5 →